Effect of BIBW 2948 BS in COPD

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Study of BIBW 2948 BS in Patients with COPD and Chronic Bronchitis

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim

Criteria

Inclusion Criteria:

• COPD smokers

• ages between 40 and 70

Exclusion Criteria:

• Significant other diseases

• abnormal hematology

• abnormal liver function

• psychiatric disorders

• pulmonary obstruction

• asthma, allergic rhinitis

• dependance on oxygen

• patients with history of myocardial infarction

• patients with history of cancer

• women of child bearing potential

• antiplatelet or anticoagulation therapy